Nonradioactive, colorimetric microplate hybridization assay for detecting amplified human immunodeficiency virus DNA. 1993

J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
Division of HIV/AIDS, Centers for Disease Control, Atlanta, GA 30333.

A nonradioactive, colorimetric microplate hybridization procedure was used to assay human immunodeficiency virus (HIV) DNA, amplified by the polymerase chain reaction (PCR). Under the PCR conditions used, four proviral copies per 150,000 cells were detected by amplifying a series of DNA mixtures that contained various copy numbers of HIV. Assays of PCR-amplified DNA from peripheral blood mononuclear cells of seronegative individuals yielded negative results (104 of 104), whereas samples from seropositive individuals yielded > 99% positive results (141 of 142). Similar results were obtained in a chemiluminescent assay with an acridinium ester-labeled probe and in a solution hybridization assay in which a 32P-labeled probe was used.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D003124 Colorimetry Any technique by which an unknown color is evaluated in terms of standard colors. The technique may be visual, photoelectric, or indirect by means of spectrophotometry. It is used in chemistry and physics. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
March 1996, Journal of clinical microbiology,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
September 1995, Journal of virological methods,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
October 2011, Journal of virological methods,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
June 1990, Journal of clinical microbiology,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
March 1993, Journal of clinical microbiology,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
July 1996, BioTechniques,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
December 2001, The Southeast Asian journal of tropical medicine and public health,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
March 1995, Journal of clinical microbiology,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
July 1992, Journal of virological methods,
J M Rapier, and Y Villamarzo, and G Schochetman, and C Y Ou, and C L Brakel, and J Donegan, and W Maltzman, and S Lee, and D Kirtikar, and D Gatica
June 1999, Biotechnology and applied biochemistry,
Copied contents to your clipboard!